Shridharani Sachin M, Palm Melanie D, Jarmuz Theresa, Somenek Michael, Nayak Laxmeesh M, Saadat David, Indeyeva Yula, Sykes Jonathan
Aesthet Surg J Open Forum. 2025 Jul 4;7:ojaf087. doi: 10.1093/asjof/ojaf087. eCollection 2025.
The rise in minimally invasive treatments (MITs) in aesthetic medicine has introduced new complexities for subsequent facial surgeries such as facelifts. Despite their popularity, there are limited data on how these treatments impact surgical outcomes.
The authors of this paper explore the impact of MIT modalities on subsequent facial surgeries and provide guidelines for perioperative planning and management to optimize outcomes for patients with a history of MITs.
An expert panel of 7 plastic surgeons and 1 dermatologist conducted a comprehensive review of existing literature, combined with author surveys and case-based discussions, to develop perioperative recommendations for patients with previous MITs. Consensus was reached for each recommendation with a ≥75% agreement threshold.
The authors of this paper present recommendations for perioperative planning, surgical techniques, and postoperative care for patients with previous MITs. Complication risks were found to vary by MIT modality: biostimulatory injectables, temporary fillers, and superficial energy-based devices (EBDs) generally present lower risks, whereas permanent fillers, deeply delivered EBDs, and recently placed temporary fillers or threads were associated with increased risks. The recommendations highlight strategies to support both aesthetic and functional surgical outcomes.
Patients with previous MITs can be candidates for facelift surgery if perioperative strategies are followed to mitigate risks associated with plane distortion and vascular compromise. These guidelines provide a framework to support aesthetic providers in enhancing surgical outcomes and patient satisfaction. Given the limited literature on MIT-related surgical implications, the authors emphasize individualized approaches to mitigate risks associated with previous MITs until further research is available.
美容医学中微创治疗（MITs）的兴起给后续面部手术（如面部提升术）带来了新的复杂性。尽管这些治疗很受欢迎，但关于它们如何影响手术结果的数据有限。
本文作者探讨了MIT模式对后续面部手术的影响，并为围手术期规划和管理提供指导方针，以优化有MIT病史患者的手术效果。
一个由7名整形外科医生和1名皮肤科医生组成的专家小组对现有文献进行了全面综述，并结合作者调查和基于病例的讨论，为有过MIT的患者制定围手术期建议。每项建议达成的共识阈值≥75%。
本文作者提出了针对有过MIT的患者围手术期规划、手术技术和术后护理的建议。发现并发症风险因MIT模式而异：生物刺激注射剂、临时填充物和浅表能量设备（EBDs）一般风险较低，而永久性填充物、深部递送的EBDs以及最近植入的临时填充物或线则与风险增加相关。这些建议强调了支持美学和功能手术效果的策略。
如果遵循围手术期策略以减轻与平面扭曲和血管受损相关的风险，有过MIT的患者可以成为面部提升手术的候选者。这些指南提供了一个框架，以支持美容提供者提高手术效果和患者满意度。鉴于关于MIT相关手术影响的文献有限，作者强调在有更多研究之前采取个体化方法来减轻与既往MIT相关的风险。
